Quantcast
Don't Miss

Intrexon closes deal with Trans Ova

Intrexon Corp., of Germantown, a synthetic biology company, announced it has completed the acquisition of Trans Ova Genetics L.C., an Iowa-based provider of bovine reproductive technologies.  Trans Ova will function as a wholly owned subsidiary of Intrexon. Trans Ova stockholders received $60 million in cash, $30 million in Intrexon common stock and $20 million in deferred payments to be paid in three equal installments upon the first, second and third anniversaries of the closing date.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 
Scroll To Top